B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B
Clinical trial NCT04193189 · COMPLETED
Trial details
- NCT number
- NCT04193189
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2024-08-13
- Enrollment
- 638
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.